{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:43:08Z","timestamp":1792269788056,"version":"4.4.0"},"reference-count":206,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p><jats:italic>Helicobacter pylori<\/jats:italic> (<jats:italic>H. pylori<\/jats:italic>) is a strict microaerophilic bacterial species that exists in the stomach, and <jats:italic>H. pylori<\/jats:italic> infection is one of the most common chronic bacterial infections affecting humans. Eradicating <jats:italic>H. pylori<\/jats:italic> is the preferred method for the long-term prevention of complications such as chronic gastritis, peptic ulcers, gastric mucosa-associated lymphoid tissue lymphoma, and gastric cancer. However, first-line treatment with triple therapy and quadruple therapy has been unable to cope with increasing antibacterial resistance. To provide an updated review of <jats:italic>H. pylori<\/jats:italic> infections and antibacterial resistance, as well as related treatment options, we searched PubMed for articles published until March 2024. The key search terms were \u201c<jats:italic>H. pylori<\/jats:italic>\u201d, \u201c<jats:italic>H. pylori<\/jats:italic> infection\u201d, \u201c<jats:italic>H. pylori<\/jats:italic> diseases\u201d, \u201c<jats:italic>H. pylori<\/jats:italic> eradication\u201d, and \u201c<jats:italic>H. pylori<\/jats:italic> antibacterial resistance.\u201d Despite the use of antimicrobial agents, the annual decline in the eradication rate of <jats:italic>H. pylori<\/jats:italic> continues. Emerging eradication therapies, such as the development of the new strong acid blocker vonoprazan, probiotic adjuvant therapy, and <jats:italic>H. pylori<\/jats:italic> vaccine therapy, are exciting. However, the effectiveness of these treatments needs to be further evaluated. It is worth mentioning that the idea of altering the oxygen environment in gastric juice for <jats:italic>H. pylori<\/jats:italic> to not be able to survive is a hot topic that should be considered in new eradication plans. Various strategies for eradicating <jats:italic>H. pylori<\/jats:italic>, including antibacterials, vaccines, probiotics, and biomaterials, are continuously evolving. A novel approach involving the alteration of the oxygen concentration within the growth environment of <jats:italic>H. pylori<\/jats:italic> has emerged as a promising eradication strategy.<\/jats:p>","DOI":"10.3389\/fmicb.2024.1418129","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:03:01Z","timestamp":1718132581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Novel therapeutic regimens against Helicobacter pylori: an updated systematic review"],"prefix":"10.3389","volume":"15","author":[{"given":"Ting-Ting","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Xiao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2217\/fvl.13.58","article-title":"Isolation and characterization of bacteriophages of Helicobacter pylori isolated from Egypt","volume":"8","author":"Abdel-Haliem","year":"2013","journal-title":"Future Virol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e0463322","DOI":"10.1128\/spectrum.04633-22","article-title":"Regulation of Helicobacter pylori urease and acetone carboxylase genes by nitric oxide and the CrdRS two-component system","volume":"11","author":"Allen","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/medicina56040169","article-title":"Prevalence of Helicobacter pylori infection and diagnostic methods in the Middle East and North Africa region","volume":"56","author":"Alsulaimany","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/MCG.0000000000001328","article-title":"10-Day versus 14-day quadruple concomitant nonbismuth therapy for the treatment of Helicobacter pylori infection: results from a randomized prospective study in a high clarithromycin resistance country","volume":"54","author":"Apostolopoulos","year":"2020","journal-title":"J. Clin. Gastroenterol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e12927","DOI":"10.1111\/hel.12927","article-title":"Helicobacter pylori infection and risk of multiple sclerosis: an updated meta-analysis","volume":"27","author":"Arjmandi","year":"2022","journal-title":"Helicobacter"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.sab.2005.05.035","article-title":"Controlled inert gas environment for enhanced chlorine and fluorine detection in the visible and near-infrared by laser-induced breakdown spectroscopy","volume":"60","author":"Asimellis","year":"2005","journal-title":"Spectrochimica Acta Part B-Atomic Spectroscopy"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4314\/thrb.v16i1.3","article-title":"Upper gastrointestinal endoscopic findings and prevalence of Helicobacter pylori infection among adult patients with dyspepsia in northern Tanzania","volume":"16","author":"Ayana","year":"2014","journal-title":"Tanzan. J. Health Res."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-3-031-46891-9_15","article-title":"Systemic inflammation as the health-related communication tool between the human host and gut microbiota in the framework of predictive, preventive, and personalized medicine","volume-title":"All around suboptimal health: Advanced approaches by predictive, preventive and personalised medicine for healthy populations","author":"Behzadi","year":"2024"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s15010-023-02159-9","article-title":"Infiltration to infection: key virulence players of Helicobacter pylori pathogenicity","volume":"52","author":"Bhattacharjee","year":"2024","journal-title":"Infection"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1097\/CM9.0000000000002289","article-title":"Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial","volume":"135","author":"Bi","year":"2022","journal-title":"Chin. Med. J."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1073\/pnas.0506655103","article-title":"Molecular analysis of the bacterial microbiota in the human stomach","volume":"103","author":"Bik","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e12924","DOI":"10.1111\/hel.12924","article-title":"Helicobacter pylori infection prevalence in ambulatory settings in 2017-2019 in RUSSIA: the data of real-world national multicenter trial","volume":"27","author":"Bordin","year":"2022","journal-title":"Helicobacter"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/children10020403","article-title":"Current worldwide trends in pediatric Helicobacter pylori antimicrobial resistance","volume":"10","author":"Borka Balas","year":"2023","journal-title":"Children (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.anpede.2020.10.010","article-title":"Antibiotic resistances and eradication rates in Helicobacter pylori infection","volume":"95","author":"Botija","year":"2021","journal-title":"An Pediatr. (Engl Ed)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/antibiotics12020332","article-title":"Evolution of Helicobacter pylori resistance to antibiotics: a topic of increasing concern","volume":"12","author":"Boyanova","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2217\/fmb-2020-0084","article-title":"Rifamycin use for treatment of Helicobacter pylori infection: a review of recent data","volume":"15","author":"Boyanova","year":"2020","journal-title":"Future Microbiol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.14309\/ajg.0000000000002600","article-title":"Effectiveness of Helicobacter pylori treatments according to antibiotic resistance","volume":"119","author":"Bujanda","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"781333","DOI":"10.3389\/fnut.2021.781333","article-title":"Vitamins and Helicobacter pylori: an updated comprehensive Meta-analysis and systematic review","volume":"8","author":"Cai","year":"2021","journal-title":"Front. Nutr."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e12715","DOI":"10.1111\/hel.12715","article-title":"Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux","volume":"25","author":"Cai","year":"2020","journal-title":"Helicobacter"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"629163","DOI":"10.3389\/fmicb.2021.629163","article-title":"Carbonic anhydrases: new perspectives on protein functional role and inhibition in Helicobacter pylori","volume":"12","author":"Campestre","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00284-024-03642-8","article-title":"Chitosan-LeoA-DNA nanoparticles promoted the efficacy of novel LeoA-DNA vaccination on mice against Helicobacter pylori","volume":"81","author":"Chaleshtori","year":"2024","journal-title":"Curr. Microbiol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1186\/s12889-023-16689-2","article-title":"Triple therapy for Helicobacter pylori eradication and the risk of hypoglycemia in patients with diabetes: a population-based cohort study","volume":"23","author":"Chang","year":"2023","journal-title":"BMC Public Health"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"116981","DOI":"10.1016\/j.jep.2023.116981","article-title":"In vitro anti-bactrical activity and its preliminary mechanism of action of the non-medicinal parts of Sanguisorba officinalis L. against Helicobacter pylori infection","volume":"318","author":"Chen","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/pathogens11070786","article-title":"Primary antibiotic resistance of Helicobacter pylori in different regions of China: a systematic review and meta-analysis","volume":"11","author":"Chen","year":"2022","journal-title":"Pathogens"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of Helicobacter pylori infection and incidence of gastric Cancer between 1980 and 2022","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3390\/ijms241713644","article-title":"Dimethylaminododecyl methacrylate-incorporated dental materials could be the first line of defense against Helicobacter pylori","volume":"24","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"10006","DOI":"10.3390\/microorganisms12010006","article-title":"Independent risk factors predicting eradication failure of hybrid therapy for the first-line treatment of Helicobacter pylori infection","volume":"12","author":"Chen","year":"2023","journal-title":"Microorganisms"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/hel.12014","article-title":"Relationship between Helicobacter pylori infection and serum interleukin-18 in patients with carotid atherosclerosis","volume":"18","author":"Chen","year":"2013","journal-title":"Helicobacter"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12941-018-0259-8","article-title":"Application of next-generation sequencing to characterize novel mutations in clarithromycin-susceptible Helicobacter pylori strains with A2143G of 23S rRNA gene","volume":"17","author":"Chen","year":"2018","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e1172","DOI":"10.1002\/mbo3.1172","article-title":"Application of a semi-automatic, intensive follow-up for improving efficacy and adherence of Helicobacter pylori eradication therapy: a randomized controlled trial","volume":"10","author":"Chen","year":"2021","journal-title":"Microbiology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e13066","DOI":"10.1111\/hel.13066","article-title":"Antagonizing roles of SHP1 in the pathogenesis of Helicobacter pylori infection","volume":"29","author":"Chen","year":"2024","journal-title":"Helicobacter"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41395-018-0132-6","article-title":"Correction: ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"113","author":"Chey","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e12890","DOI":"10.1111\/hel.12890","article-title":"Does technology-enhanced communication improve Helicobacter pylori eradication outcomes?-a meta-analysis","volume":"27","author":"Chua","year":"2022","journal-title":"Helicobacter"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrmicro1095","article-title":"Helicobacter pylori VacA, a paradigm for toxin multifunctionality","volume":"3","author":"Cover","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3390\/microorganisms8081214","article-title":"An innovative approach to control H. pylori-induced persistent inflammation and colonization","volume":"8","author":"Cuomo","year":"2020","journal-title":"Microorganisms"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrgastro.2011.1","article-title":"Vaccinating against Helicobacter pylori infection","volume":"8","author":"Czinn","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3892\/etm.2022.11153","article-title":"Study on the value of antibiotic-resistant gene detection in Helicobacter pylori in China","volume":"23","author":"Dai","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1360852","DOI":"10.3389\/fcimb.2024.1360852","article-title":"The effects and mechanisms of natural products on Helicobacter pylori eradication","volume":"14","author":"Deng","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1128\/AAC.02192-19","article-title":"Hydrogen peroxide-mediated oxygen enrichment eradicates Helicobacter pylori in vitro and in vivo","volume":"64","author":"Di","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/microorganisms9010002","article-title":"Genomic analysis of antimicrobial resistance genotype-to-phenotype agreement in Helicobacter pylori","volume":"9","author":"Domanovich-Asor","year":"2020","journal-title":"Microorganisms"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1574-6968.1998.tb13248.x","article-title":"The effect of oxygen on the growth and cell morphology of Helicobacter pylori","volume":"168","author":"Donelli","year":"1998","journal-title":"FEMS Microbiol. Lett."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/toxins13070485","article-title":"Helicobacter pylori BabA-SabA key roles in the adherence phase: the synergic mechanism for successful colonization and disease development","volume":"13","author":"Doohan","year":"2021","journal-title":"Toxins (Basel)"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1080\/14760584.2021.1945450","article-title":"Vaccine development against Helicobacter pylori: from ideal antigens to the current landscape","volume":"20","author":"Dos Santos Viana","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3390\/microorganisms8060894","article-title":"Association between active Helicobacter pylori infection and Glaucoma: a systematic review and Meta-analysis","volume":"8","author":"Doulberis","year":"2020","journal-title":"Microorganisms"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.febslet.2009.04.027","article-title":"The secreted Helicobacter cysteine-rich protein a causes adherence of human monocytes and differentiation into a macrophage-like phenotype","volume":"583","author":"Dumrese","year":"2009","journal-title":"FEBS Lett."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.3390\/microorganisms9102033","article-title":"Helicobacter pylori and respiratory diseases: 2021 update","volume":"9","author":"Durazzo","year":"2021","journal-title":"Microorganisms"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/antibiotics12020191","article-title":"Helicobacter pylori infection: current status and future prospects on diagnostic, therapeutic and control challenges","volume":"12","author":"Elbehiry","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3390\/antibiotics12081260","article-title":"Biofilm of Helicobacter pylori: life cycle, features, and treatment options","volume":"12","author":"Elshenawi","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"8595487","DOI":"10.1155\/2019\/8595487","article-title":"Immunization with a synthetic Helicobacter pylori peptide induces secretory IgA antibodies and protects mice against infection","volume":"2019","author":"Espinosa-Ramos","year":"2019","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/toxins12080473","article-title":"Biofilm formation and antibiotic resistance phenotype of Helicobacter pylori clinical isolates","volume":"12","author":"Fauzia","year":"2020","journal-title":"Toxins (Basel)"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3238\/arztebl.2018.0429","article-title":"Helicobacter pylori infection","volume":"115","author":"Fischbach","year":"2018","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"14533","DOI":"10.1021\/acsami.3c18772","article-title":"One-pot microfluidics to engineer chitosan nanoparticles conjugated with antimicrobial peptides using \"Photoclick\" chemistry: validation using the gastric bacterium Helicobacter pylori","volume":"16","author":"Fonseca","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s42506-019-0017-6","article-title":"Helicobacter pylori among symptomatic Egyptian children: prevalence, risk factors, and effect on growth","volume":"94","author":"Galal","year":"2019","journal-title":"J. Egypt. Public Health Assoc."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1128\/AAC.00957-18","article-title":"Bifunctional enzyme SpoT is involved in biofilm formation of Helicobacter pylori with multidrug resistance by upregulating efflux pump Hp1174 (gluP)","volume":"62","author":"Ge","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vaccine.2024.02.050","article-title":"PIRES2-EGFP\/CTB-UreI vaccination activated a mixed Th1\/Th2\/Th17 immune system defense towards Helicobacter pylori infection in the BALB\/c mice model","author":"Ghasemifar","year":"2024","journal-title":"Vaccine"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5662\/wjm.v5.i3.164","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a recent literature review","volume":"5","author":"Ghotaslou","year":"2015","journal-title":"World J Methodol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/pathogens10010015","article-title":"Rifabutin for the treatment of Helicobacter pylori infection: a review","volume":"10","author":"Gisbert","year":"2020","journal-title":"Pathogens"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"12392","DOI":"10.1111\/hel.12392","article-title":"Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies","volume":"22","author":"Gisbert","year":"2017","journal-title":"Helicobacter"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"294","DOI":"10.5114\/pg.2020.101557","article-title":"Clinical and laboratory importance of detecting Helicobacter pylori coccoid forms for the selection of treatment","volume":"15","author":"Gladyshev","year":"2020","journal-title":"Prz Gastroenterol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/antibiotics9100671","article-title":"Transitioning of Helicobacter pylori therapy from trial and error to antimicrobial stewardship","volume":"9","author":"Graham","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ijmm.2018.08.002","article-title":"Thioloxidoreductase HP0231 of Helicobacter pylori impacts HopQ-dependent CagA translocation","volume":"308","author":"Grzeszczuk","year":"2018","journal-title":"Int. J. Med. Microbiol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3389\/fimmu.2019.01185","article-title":"Therapeutic protection against H. pylori infection in Mongolian gerbils by Oral immunization with a tetravalent epitope-based vaccine with polysaccharide adjuvant","volume":"10","author":"Guo","year":"2019","journal-title":"Front. Immunol."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/jac\/dkab415","article-title":"Timing of prior exposure to antibiotics and failure of Helicobacter pylori eradication: a population-based study","volume":"77","author":"Guo","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"918160","DOI":"10.3389\/fimmu.2022.918160","article-title":"Oral immunization with a M cell-targeting recombinant L. lactis vaccine LL-plSAM-FVpE stimulate protective immunity against H. pylori in mice","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Immunol."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"102443","DOI":"10.1016\/j.isci.2021.102443","article-title":"Mimicking biofilm formation and development: recent progress in in vitro and in vivo biofilm models","volume":"24","author":"Guzman-Soto","year":"2021","journal-title":"iScience"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/88563","article-title":"Supramolecular assembly and acid resistance of Helicobacter pylori urease","volume":"8","author":"Ha","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"114939","DOI":"10.1016\/j.bios.2022.114939","article-title":"Harnessing enhanced CRISPR\/Cas12a trans-cleavage activity with extended reporters and reductants for early diagnosis of Helicobacter pylori, the causative agent of peptic ulcers and stomach cancer","volume":"222","author":"Habimana","year":"2023","journal-title":"Biosens. Bioelectron."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"e14872","DOI":"10.7759\/cureus.14872","article-title":"Helicobacter pylori eradication therapy: still a challenge","volume":"13","author":"Hafeez","year":"2021","journal-title":"Cureus"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1046\/j.1440-1746.2000.02131.x","article-title":"Effect of age and Helicobacter pylori infection on gastric acid secretion","volume":"15","author":"Haruma","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-med-080219-122208","article-title":"Phage therapy for antibiotic-resistant bacterial infections","volume":"73","author":"Hatfull","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41522-020-00167-3","article-title":"Genetic requirements and transcriptomics of Helicobacter pylori biofilm formation on abiotic and biotic surfaces","volume":"6","author":"Hathroubi","year":"2020","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1016\/j.celrep.2017.08.080","article-title":"Differential mechanisms for SHP2 binding and activation are exploited by geographically distinct Helicobacter pylori CagA Oncoproteins","volume":"20","author":"Hayashi","year":"2017","journal-title":"Cell Rep."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"e12898","DOI":"10.1111\/hel.12898","article-title":"Probiotics mitigate Helicobacter pylori-induced gastric inflammation and premalignant lesions in INS-GAS mice with the modulation of gastrointestinal microbiota","volume":"27","author":"He","year":"","journal-title":"Helicobacter"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1033063","DOI":"10.3389\/fimmu.2022.1033063","article-title":"Probiotics modulate gastrointestinal microbiota after Helicobacter pylori eradication: a multicenter randomized double-blind placebo-controlled trial","volume":"13","author":"He","year":"","journal-title":"Front. Immunol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/pathogens11020178","article-title":"Increased antibiotic resistance in children with Helicobacter pylori infection: a retrospective study","volume":"11","author":"Helmbold","year":"2022","journal-title":"Pathogens"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.14309\/ajg.0000000000001828","article-title":"Helicobacter pylori antibiotic resistance in the United States between 2011 and 2021: a systematic review and Meta-analysis","volume":"117","author":"Ho","year":"2022","journal-title":"Am. J. Gastroenterol."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S2468-1253(23)00281-9","article-title":"Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis","volume":"9","author":"Hong","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"10064","DOI":"10.1073\/pnas.1901730116","article-title":"Post-stress bacterial cell death mediated by reactive oxygen species","volume":"116","author":"Hong","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.2147\/IDR.S357473","article-title":"Helicobacter pylori biofilm-related drug resistance and new developments in its anti-biofilm agents","volume":"15","author":"Hou","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"116055","DOI":"10.1016\/j.bcp.2024.116055","article-title":"Sodium sulfite-driven Helicobacter pylori eradication: unraveling oxygen dynamics through multi-omics investigation","volume":"222","author":"Huang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"116549","DOI":"10.1016\/j.taap.2023.116549","article-title":"The effects of sodium sulfite on Helicobacter pylori by establishing a hypoxic environment","volume":"470","author":"Huang","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1053\/j.gastro.2021.03.045","article-title":"National and regional US antibiotic resistance to Helicobacter pylori: lessons from a clinical trial","volume":"161","author":"Hulten","year":"2021","journal-title":"Gastroenterology"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"e3062","DOI":"10.7759\/cureus.3062","article-title":"Vitamin C: a preventative, Therapeutic Agent Against Helicobacter pylori","volume":"10","author":"Hussain","year":"2018","journal-title":"Cureus"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/antibiotics9060293","article-title":"The puzzle of coccoid forms of Helicobacter pylori: beyond basic science","volume":"9","author":"Ierardi","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10120-016-0658-5","article-title":"Changing epidemiology of Helicobacter pylori in Japan","volume":"20","author":"Inoue","year":"2017","journal-title":"Gastric Cancer"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"e0186629","DOI":"10.1371\/journal.pone.0186629","article-title":"Sulfites inhibit the growth of four species of beneficial gut bacteria at concentrations regarded as safe for food","volume":"12","author":"Irwin","year":"2017","journal-title":"PLoS One"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1093\/jac\/dky011","article-title":"Gentamicin-intercalated smectite as a new therapeutic option for Helicobacter pylori eradication","volume":"73","author":"Jeong","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/antibiotics9080502","article-title":"Efficacy and gut Dysbiosis of gentamicin-intercalated Smectite as a new therapeutic agent against Helicobacter pylori in a mouse model","volume":"9","author":"Jeong","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"e12893","DOI":"10.1111\/hel.12893","article-title":"Age of eradication and failure rates of clarithromycin-containing triple therapy for Helicobacter pylori: a 15-year population-based study","volume":"27","author":"Jiang","year":"2022","journal-title":"Helicobacter"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.biomaterials.2016.01.045","article-title":"Design and evaluation of novel pH-sensitive ureido-conjugated chitosan\/TPP nanoparticles targeted to Helicobacter pylori","volume":"84","author":"Jing","year":"2016","journal-title":"Biomaterials"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/14787210.2019.1646126","article-title":"Factors determining phage stability\/activity: challenges in practical phage application","volume":"17","author":"Jonczyk-Matysiak","year":"2019","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"e12690","DOI":"10.1111\/hel.12690","article-title":"Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: a randomized controlled trial","volume":"25","author":"Kakiuchi","year":"2020","journal-title":"Helicobacter"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"2303853","DOI":"10.1080\/21505594.2024.2303853","article-title":"Gut-brain axis interplay via STAT3 pathway: implications of Helicobacter pylori derived secretome on inflammation and Alzheimer's disease","volume":"15","author":"Kandpal","year":"2024","journal-title":"Virulence"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.micres.2018.09.011","article-title":"Helicobacter pylori evasion strategies of the host innate and adaptive immune responses to survive and develop gastrointestinal diseases","volume":"218","author":"Karkhah","year":"2019","journal-title":"Microbiol. Res."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.2147\/IDR.S250200","article-title":"Primary resistance pattern of Helicobacter pylori to antibiotics in adult population: a systematic review","volume":"13","author":"Kasahun","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"e12997","DOI":"10.1111\/hel.12997","article-title":"Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines","volume":"28","author":"Katsande","year":"2023","journal-title":"Helicobacter"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12865-024-00602-6","article-title":"Oral administration of DNA alginate nanovaccine induced immune-protection against Helicobacter pylori in Balb\/C mice","volume":"25","author":"Kaveh-Samani","year":"2024","journal-title":"BMC Immunol."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"21460","DOI":"10.1002\/jcp.28870","article-title":"Potential antigen candidates for subunit vaccine development against Helicobacter pylori infection","volume":"234","author":"Keikha","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref99","doi-asserted-by":"crossref","DOI":"10.1128\/9781555818005.ch10","article-title":"Microaerobic physiology: aerobic respiration, anaerobic respiration, and carbon dioxide metabolism","volume-title":"Helicobacter pylori","author":"Kelly","year":"2001"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"6790","DOI":"10.3748\/wjg.v25.i46.6790","article-title":"Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: a prospective open-label randomized trial","volume":"25","author":"Kim","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/pathogens9030184","article-title":"Transformation of Helicobacter pylori into coccoid forms as a challenge for research determining activity of antimicrobial substances","volume":"9","author":"Krzyzek","year":"2020","journal-title":"Pathogens"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/biom8010004","article-title":"Antimicrobial peptides: diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo","volume":"8","author":"Kumar","year":"2018","journal-title":"Biomol. Ther."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"e4022","DOI":"10.1002\/cbf.4022","article-title":"Bacteriophages as a potential substitute for antibiotics: a comprehensive review","volume":"42","author":"Kushwaha","year":"2024","journal-title":"Cell Biochem. Funct."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2169\/internalmedicine.2233-18","article-title":"Effect of age on effectiveness of vonoprazan in triple therapy for Helicobacter pylori eradication","volume":"58","author":"Kusunoki","year":"2019","journal-title":"Intern. Med."},{"key":"ref105","first-page":"726","article-title":"Medium-or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease","volume":"89","author":"Labenz","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3390\/antibiotics11060757","article-title":"Treatment of pediatric Helicobacter pylori infection","volume":"11","author":"Lai","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/jcm8010053","article-title":"Genetic determinants and prediction of antibiotic resistance phenotypes in Helicobacter pylori","volume":"8","author":"Lauener","year":"2019","journal-title":"J. Clin. Med."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s15010-022-01948-y","article-title":"Management of Helicobacter pylori infection in paediatric patients in Europe: results from the EuroPedHp registry","volume":"51","author":"Le Thi","year":"2023","journal-title":"Infection"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3947\/ic.2019.51.1.10","article-title":"Can aminoglycosides be used as a new treatment for Helicobacter pylori? In vitro activity of recently isolated Helicobacter pylori","volume":"51","author":"Lee","year":"2019","journal-title":"Infect. Chemother."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/mmi.12923","article-title":"Characterization of Helicobacter pylori HP0231 (DsbK): role in disulfide bond formation, redox homeostasis and production of Helicobacter cystein-rich protein HcpE","volume":"96","author":"Lester","year":"2015","journal-title":"Mol. Microbiol."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/hel.12268","article-title":"Antibody production and Th1-biased response induced by an epitope vaccine composed of cholera toxin B unit and Helicobacter pylori Lpp20 epitopes","volume":"21","author":"Li","year":"2016","journal-title":"Helicobacter"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","article-title":"Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/2049-632X.12173","article-title":"Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice","volume":"72","author":"Li","year":"2014","journal-title":"Pathog. Dis."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"e0204762","DOI":"10.1371\/journal.pone.0204762","article-title":"Trends in the seroprevalence of Helicobacter pylori infection and its putative eradication rate over 18 years in Korea: a cross-sectional nationwide multicenter study","volume":"13","author":"Lim","year":"2018","journal-title":"PLoS One"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"1330029","DOI":"10.3389\/fmicb.2023.1330029","article-title":"Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1016\/j.vaccine.2020.02.036","article-title":"Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection","volume":"38","author":"Liu","year":"2020","journal-title":"Vaccine"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1080\/07388551.2020.1796576","article-title":"Antimicrobial peptides as therapeutic agents: opportunities and challenges","volume":"40","author":"Mahlapuu","year":"2020","journal-title":"Crit. Rev. Biotechnol."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S0140-6736(02)08025-X","article-title":"Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood","volume":"359","author":"Malaty","year":"2002","journal-title":"Lancet"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence consensus report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000538079","article-title":"H. pylori infection: a 40-year journey through shifting the paradigm to transforming the management","author":"Malfertheiner","year":"2024","journal-title":"Dig. Dis."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1136\/gutjnl-2021-324032","article-title":"Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community","volume":"70","author":"Megraud","year":"2021","journal-title":"Gut"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1128\/cdli.10.4.542-545.2003","article-title":"Detection of high titers of antibody against Helicobacter cysteine-rich proteins a, B, C, and E in Helicobacter pylori-infected individuals","volume":"10","author":"Mittl","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40495-023-00342-y","article-title":"Antimicrobial Peptides","volume":"9","author":"Mohaideen","year":"2023","journal-title":"Curr. Pharmacol. Rep."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1099\/0022-1317-49-9-817","article-title":"Profiling of bacterial flora in gastric biopsies from patients with Helicobacter pylori-associated gastritis and histologically normal control individuals by temperature gradient gel electrophoresis and 16S rDNA sequence analysis","volume":"49","author":"Monstein","year":"2000","journal-title":"J. Med. Microbiol."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.vaccine.2010.12.130","article-title":"HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model","volume":"29","author":"Moss","year":"2011","journal-title":"Vaccine"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1021\/acsinfecdis.0c00300","article-title":"The discovery and development of Thienopyrimidines as inhibitors of Helicobacter pylori that act through inhibition of the respiratory complex I","volume":"7","author":"Mugengana","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3164\/jcbn.20-37","article-title":"Effectiveness of including probiotics to Helicobacter pylori eradication therapies","volume":"67","author":"Mukai","year":"2020","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"549084","DOI":"10.3389\/fmicb.2020.549084","article-title":"Bacteriophages of Helicobacter pylori","volume":"11","author":"Munoz","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.micpath.2018.02.016","article-title":"Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders","volume":"117","author":"Nejati","year":"2018","journal-title":"Microb. Pathog."},{"key":"ref132","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3164\/jcbn.16-86","article-title":"Effects of patient age and choice of antisecretory agent on success of eradication therapy for Helicobacter pylori infection","volume":"60","author":"Nishizawa","year":"2017","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1073\/pnas.1211248110","article-title":"Helicobacter pylori gamma-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance","volume":"110","author":"Oertli","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"e12470","DOI":"10.1111\/hel.12470","article-title":"Monotherapy with a novel intervenolin derivative, AS-1934, is an effective treatment for Helicobacter pylori infection","volume":"23","author":"Ohishi","year":"2018","journal-title":"Helicobacter"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.3748\/wjg.v24.i32.3617","article-title":"Helicobacter pylori infection and liver diseases: epidemiology and insights into pathogenesis","volume":"24","author":"Okushin","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref136","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00004836-200007000-00008","article-title":"Prevalence of Helicobacter pylori infection in Argentina: results of a nationwide epidemiologic study. Argentinean Hp epidemiologic study group","volume":"31","author":"Olmos","year":"2000","journal-title":"J. Clin. Gastroenterol."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"6332","DOI":"10.1074\/jbc.M113.513135","article-title":"The three-dimensional structure of the extracellular adhesion domain of the sialic acid-binding adhesin SabA from Helicobacter pylori","volume":"289","author":"Pang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3345\/cep.2019.01543","article-title":"Changing prevalence of Helicobacter pylori infection in children and adolescents","volume":"64","author":"Park","year":"2021","journal-title":"Clin Exp Pediatr"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/pmic.200500293","article-title":"Comparative proteomic analysis of Helicobacter pylori strains associated with iron deficiency anemia","volume":"6","author":"Park","year":"2006","journal-title":"Proteomics"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"e12741","DOI":"10.1111\/hel.12741","article-title":"Review: Extragastric diseases and Helicobacter pylori","volume":"25","author":"Pellicano","year":"2020","journal-title":"Helicobacter"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.1038\/s41598-018-24879-x","article-title":"Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity","volume":"8","author":"Peng","year":"2018","journal-title":"Sci. Rep."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"627","DOI":"10.14309\/ajg.0000000000002086","article-title":"Ten-Day vonoprazan-amoxicillin dual therapy as a first-line treatment of Helicobacter pylori infection compared with bismuth-containing quadruple therapy","volume":"118","author":"Qian","year":"2023","journal-title":"Am. J. Gastroenterol."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13099-020-00358-5","article-title":"Antibacterial activity of ethoxzolamide against Helicobacter pylori strains SS1 and 26695","volume":"12","author":"Rahman","year":"2020","journal-title":"Gut Pathog."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1556\/030.64.2017.008","article-title":"Advances in diagnosis and treatment of Helicobacter pylori infection","volume":"64","author":"Ranjbar","year":"2017","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"ref145","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/jgh.15751","article-title":"Prevalence of Helicobacter pylori infection in China: a systematic review and meta-analysis","volume":"37","author":"Ren","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref146","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.3748\/wjg.v23.i27.4867","article-title":"Significance of dormant forms of Helicobacter pylori in ulcerogenesis","volume":"23","author":"Reshetnyak","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref147","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.gastro.2021.04.012","article-title":"Comparative effectiveness of multiple different first-line treatment regimens for Helicobacter pylori infection: a network meta-analysis","volume":"161","author":"Rokkas","year":"2021","journal-title":"Gastroenterology"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"e30543","DOI":"10.1371\/journal.pone.0030543","article-title":"Evidence for conserved function of gamma-glutamyltranspeptidase in Helicobacter genus","volume":"7","author":"Rossi","year":"2012","journal-title":"PLoS One"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1167\/iovs.05-0323","article-title":"Prevalence and treatment of Helicobacter pylori in patients with blepharitis","volume":"47","author":"Sacca","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/cancers11010116","article-title":"Vonoprazan-based third-line therapy has a higher eradication rate against Sitafloxacin-resistant Helicobacter pylori","volume":"11","author":"Saito","year":"2019","journal-title":"Cancers (Basel)"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"16026","DOI":"10.1038\/nmicrobiol.2016.26","article-title":"Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus","volume":"1","author":"Saju","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref152","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and Meta-analysis in World Health Organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/jgh.15352","article-title":"Antibiotic resistance of Helicobacter pylori in Australia and New Zealand: a systematic review and meta-analysis","volume":"36","author":"Schubert","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref154","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1111\/imj.15640","article-title":"Increasing Helicobacter pylori clarithromycin resistance in Australia over 20 years","volume":"52","author":"Schubert","year":"2022","journal-title":"Intern. Med. J."},{"key":"ref155","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1136\/gut.43.2008.s56","article-title":"The life and death of Helicobacter pylori","volume":"43","author":"Scott","year":"1998","journal-title":"Gut"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cgh.2023.05.016","article-title":"Helicobacter pylori burden in the United States according to individual demographics and geography: a Nationwide analysis of the veterans healthcare system","volume":"22","author":"Shah","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref157","first-page":"58","article-title":"Medication adherence pattern and factors affecting adherence in Helicobacter pylori eradication therapy","volume":"14","author":"Shakya Shrestha","year":"2016","journal-title":"Kathmandu Univ. Med. J. (KUMJ)"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/tropicalmed8030172","article-title":"Drug resistance patterns of commonly used antibiotics for the treatment of Helicobacter pylori infection among south Asian countries: a systematic review and Meta-analysis. Trop med","volume":"8","author":"Shrestha","year":"2023","journal-title":"Infect. Dis."},{"key":"ref159","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1159\/000518959","article-title":"Helicobacter pylori infection in Africa: update of the current situation and challenges","volume":"40","author":"Smith","year":"2022","journal-title":"Dig. Dis."},{"key":"ref160","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3389\/fmicb.2020.01340","article-title":"Outer membrane vesicles of Helicobacter pylori 7.13 as adjuvants promote protective efficacy against Helicobacter pylori infection","volume":"11","author":"Song","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"9379480","DOI":"10.1155\/2018\/9379480","article-title":"What roles do probiotics play in the eradication of Helicobacter pylori? Current knowledge and ongoing research","volume":"2018","author":"Song","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref162","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.22038\/ijbms.2021.56232.12579","article-title":"Evaluation of Helicobacter pylori OipA protein as a vaccine candidate and propolis as an adjuvant in C57BL\/6 mice","volume":"24","author":"Soudi","year":"2021","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref163","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1365-2672.1999.00481.x","article-title":"Biofilm formation by Helicobacter pylori","volume":"28","author":"Stark","year":"1999","journal-title":"Lett. Appl. Microbiol."},{"key":"ref164","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"e12967","DOI":"10.1111\/hel.12967","article-title":"Helicobacter pylori infection and risk of cardiovascular disease","volume":"28","author":"Sun","year":"2023","journal-title":"Helicobacter"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref167","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.1016\/j.vaccine.2018.01.001","article-title":"Status of vaccine research and development for Helicobacter pylori","volume":"37","author":"Sutton","year":"2019","journal-title":"Vaccine"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"e12552","DOI":"10.1111\/hel.12552","article-title":"Prevalence of Helicobacter pylori infection among junior high school students in Grudziadz, Poland","volume":"24","author":"Szaflarska-Poplawska","year":"2019","journal-title":"Helicobacter"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"e21004","DOI":"10.1016\/j.heliyon.2023.e21004","article-title":"A2BR facilitates the pathogenesis of H. pylori-associated GU by inducing oxidative stress through p38 MAPK phosphorylation","volume":"9","author":"Tang","year":"2023","journal-title":"Heliyon"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"15403","DOI":"10.1038\/s41598-020-72400-0","article-title":"Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China","volume":"10","author":"Tang","year":"2020","journal-title":"Sci. Rep."},{"key":"ref171","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","article-title":"Review article: the global emergence of Helicobacter pylori antibiotic resistance","volume":"43","author":"Thung","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref172","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.micpath.2017.02.021","article-title":"Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens","volume":"105","author":"Tobias","year":"2017","journal-title":"Microb. Pathog."},{"key":"ref173","doi-asserted-by":"publisher","first-page":"8454125","DOI":"10.1155\/2018\/8454125","article-title":"Epidemiological and clinical-pathological aspects of Helicobacter pylori infection in Brazilian children and adults","volume":"2018","author":"Toscano","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1128\/AAC.00140-17","article-title":"A randomized controlled trial shows that both 14-Day hybrid and bismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with moderate antibiotic resistance","volume":"61","author":"Tsay","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3390\/microorganisms8060887","article-title":"Next-generation sequencing of the whole bacterial genome for tracking molecular insight into the broad-Spectrum antimicrobial resistance of Helicobacter pylori clinical isolates from the Democratic Republic of Congo","volume":"8","author":"Tshibangu-Kabamba","year":"2020","journal-title":"Microorganisms"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41575-021-00449-x","article-title":"Helicobacter pylori infection and antibiotic resistance \u2013 from biology to clinical implications","volume":"18","author":"Tshibangu-Kabamba","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref177","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/CEG.S424559","article-title":"Prevalence of Oral Helicobacter pylori infection in an indigenous Community in Southwest Mexico","volume":"16","author":"Urrutia-Baca","year":"2023","journal-title":"Clin. Exp. Gastroenterol."},{"key":"ref178","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/00494755231206850","article-title":"Leveraging the multidimensional poverty index to estimate Helicobacter pylori prevalence in districts in Karnataka","volume":"54","author":"Venkatesan","year":"2024","journal-title":"India. Trop. Doct."},{"key":"ref179","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/medicina59010006","article-title":"Antibiotic resistance of Helicobacter pylori in patients with peptic ulcer","volume":"59","author":"Vu","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"833424","DOI":"10.3389\/fimmu.2022.833424","article-title":"Helicobacter pylori and autoimmune diseases: involving multiple systems","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"ref181","doi-asserted-by":"publisher","first-page":"1259579","DOI":"10.3389\/fmicb.2023.1259579","article-title":"Causality of anti-Helicobacter pylori IgG levels on myocardial infarction and potential pathogenesis: a Mendelian randomization study","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref182","doi-asserted-by":"publisher","first-page":"673993","DOI":"10.3389\/fcell.2021.673993","article-title":"Role of outer membrane vesicles from Helicobacter pylori in atherosclerosis","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref183","doi-asserted-by":"publisher","first-page":"687","DOI":"10.14740\/jocmr4348","article-title":"The prevalence of Helicobacter pylori infection in a quaternary Hospital in Canada","volume":"12","author":"Willems","year":"2020","journal-title":"J. Clin. Med. Res."},{"key":"ref184","doi-asserted-by":"publisher","first-page":"12675","DOI":"10.1073\/pnas.1710408114","article-title":"Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides","volume":"114","author":"Xiong","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"e1971","DOI":"10.1038\/cddis.2015.329","article-title":"Helicobacter pylori VacA toxin causes cell death by inducing accumulation of cytoplasmic connexin 43","volume":"6","author":"Yahiro","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref186","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/femspd\/ftv026","article-title":"Protection against Helicobacter pylori infection in BALB\/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB","volume":"73","author":"Yang","year":"2015","journal-title":"Pathog Dis"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"54316","DOI":"10.1021\/acsami.0c13101","article-title":"Residence time-extended nanoparticles by magnetic field improve the eradication efficiency of Helicobacter pylori","volume":"12","author":"Yang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"e12856","DOI":"10.1111\/hel.12856","article-title":"Effects of non-viable Lactobacillus reuteri combining with 14-day standard triple therapy on Helicobacter pylori eradication: a randomized double-blind placebo-controlled trial","volume":"26","author":"Yang","year":"2021","journal-title":"Helicobacter"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"437","DOI":"10.14309\/ajg.0000000000000132","article-title":"Eradication efficacy of modified dual therapy compared with bismuth-containing quadruple therapy as a first-line treatment of Helicobacter pylori","volume":"114","author":"Yang","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref190","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.micpath.2019.04.030","article-title":"Effect of Helicobacter pylori biofilm formation on susceptibility to amoxicillin, metronidazole and clarithromycin","volume":"132","author":"Yonezawa","year":"2019","journal-title":"Microb. Pathog."},{"key":"ref191","doi-asserted-by":"publisher","first-page":"e2206957","DOI":"10.1002\/advs.202206957","article-title":"Gastric acid-responsive ROS nanogenerators for effective treatment of Helicobacter pylori infection without disrupting homeostasis of intestinal flora","volume":"10","author":"Yu","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2352-4642(21)00400-4","article-title":"The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis","volume":"6","author":"Yuan","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"e12848","DOI":"10.1111\/hel.12848","article-title":"The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults","volume":"26","author":"Yuan","year":"2021","journal-title":"Helicobacter"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"e13034","DOI":"10.1111\/hel.13034","article-title":"Advances in Helicobacter pylori vaccine research: from candidate antigens to adjuvants-a review","volume":"29","author":"Yunle","year":"2024","journal-title":"Helicobacter"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0140-6736(15)60310-5","article-title":"Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"Zeng","year":"2015","journal-title":"Lancet"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s10120-023-01461-7","article-title":"Sustained exposure to Helicobacter pylori induces immune tolerance by desensitizing TLR6","volume":"27","author":"Zhang","year":"2024","journal-title":"Gastric Cancer"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"10838","DOI":"10.12998\/wjcc.v9.i35.10838","article-title":"Ninety-four thousand-case retrospective study on antibacterial drug resistance of Helicobacter pylori","volume":"9","author":"Zhang","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"ref198","doi-asserted-by":"publisher","first-page":"894206","DOI":"10.3389\/fimmu.2022.894206","article-title":"Oral administration of a shigella 2aT32-based vaccine expressing UreB-HspA fusion antigen with and without parenteral rUreB-HspA boost confers protection against Helicobacter pylori in mice model","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"ref199","doi-asserted-by":"publisher","first-page":"e12956","DOI":"10.1111\/hel.12956","article-title":"New regimens as first-line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: a randomized controlled trial","volume":"28","author":"Zhang","year":"2023","journal-title":"Helicobacter"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"e2301724","DOI":"10.1002\/advs.202301724","article-title":"A bioresponsive genetically encoded antimicrobial crystal for the Oral treatment of Helicobacter pylori infection","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1128\/AAC.00152-21","article-title":"SpoT-mediated NapA upregulation promotes oxidative stress-induced Helicobacter pylori biofilm formation and confers multidrug resistance","volume":"65","author":"Zhao","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref202","doi-asserted-by":"publisher","first-page":"8972473","DOI":"10.1155\/2020\/8972473","article-title":"Telephone-based reeducation of drug administration for Helicobacter pylori eradication: a multicenter randomized controlled study","volume":"2020","author":"Zhao","year":"2020","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref203","doi-asserted-by":"publisher","first-page":"e13043","DOI":"10.1111\/hel.13043","article-title":"Helicobacter pylori infection and inflammasomes","volume":"29","author":"Zheng","year":"2024","journal-title":"Helicobacter"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CM9.0000000000002884","article-title":"Antibiotic resistance in Helicobacter pylori among children and adolescents in East Asia: a systematic review and meta-analysis","author":"Zhou","year":"2024","journal-title":"Chin. Med. J."},{"key":"ref205","doi-asserted-by":"publisher","first-page":"26418","DOI":"10.1021\/acsami.2c04683","article-title":"Ultrasound-activated persistent luminescence imaging and Bacteria-triggered drug release for Helicobacter pylori infection Theranostics","volume":"14","author":"Zhou","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"1756284820937115","DOI":"10.1177\/1756284820937115","article-title":"High dose PPI-amoxicillin dual therapy for the treatment of Helicobacter pylori infection: a systematic review with meta-analysis","volume":"13","author":"Zhu","year":"2020","journal-title":"Ther. Adv. Gastroenterol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1418129\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:03:12Z","timestamp":1718132592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1418129\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":206,"alternative-id":["10.3389\/fmicb.2024.1418129"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1418129","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,7]]},"article-number":"1418129"}}